12 October 2019
Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA.
Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture optomap® image with guided OCT allowing advanced OCT imaging anywhere across the retina, from posterior pole to far periphery. This provides unparalleled UWF guided multimodal imaging in support of detection, investigation and monitoring of retinal disease.
Silverstone provides greater imaging functionality and expands the Company’s product portfolio for ophthalmic markets. It combines colour, autofluorescence (AF), fluorescein (FA) and Indocyanine Green (ICG) angiography with Swept Source OCT imaging capabilities. A comprehensive exam that includes an ultra-widefield optomap® image has been shown in clinical studies to enhance pathology detection and disease management, as well as to improve clinic flow. Now by integrating swept source OCT, Silverstone further facilitates examination of the retina from vitreous through the choroidal-scleral interface and helps guide treatment decisions.
World Sight Day (WSD) is an annual day of awareness held on the second Thursday of October each year. WSD aims to focus global attention on blindness and vision impairment. The International Agency for the Prevention of Blindness (IAPB) members work together to raise public awareness of blindness and vision impairment, influence governments to participate and designate funds for national blindness prevention funds, and to educate target audiences about blindness prevention. World Sight Day 2019 takes place on October 10th. This year’s theme and call to action is “Vision First!”.
Of all the people suffering from blindness or poor vision, more than a billion people suffer because they do not have access to proper eye care. This year’s mission urges everyone to find solutions to ensure that everyone, everywhere has access to proper eye care.
Continued studies conducted by the IAPB have concluded that 80% of eyes can be saved from blindness, given the proper comprehensive care and diagnosis. Additional facts from these studies include
285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 million have low vision.About 90% of the world’s visually impaired live in low-income settings.80% of all visual …
Results from a recent publication call for the use of consistent nomenclature when describing the field of view captured by retinal images. The International Widefield Imaging Study Group has proposed the need for consistent nomenclature for widefield and ultra-widefield imaging based on normal anatomic landmarks. When describing the area captured by an imaging modality, it is important to be consistent in meaning so the capabilities of the technology are clear to the reader.
The panel defines ultra-widefield as images showing retinal anatomy anterior to the vortex vein ampullae in all four quadrants. Widefield is defined as an image centered on the fovea and includes the retina in all four quadrants posterior to and including the vortex vein ampullae. The panel recommends this standardized nomenclature for use in future publications1.
Over the last decade, many large studies have underlined the importance of appropriately imaging the periphery to support the detection and management of disease in a variety of areas including telemedicine screening2,3,4, diabetic retinopathy5,6, age-related maculardegeneration7, vascular disease8, pediatric retinal disease9, inflammatory disease10,11,12 and even some systemic diseases. Consistently, optomap imaging has been demonstrated to capture the widest field of view in a single capture of any imaging technology14,15,16,17.
As the leaders in ultra-widefield (UWF™) retinal imaging technology, Optos would like to invite you to join us at the International Vision Expo West (VEW) September 18-21 at the Sands Expo in Las Vegas. Explore what’s new at Optos by pre-scheduling your demonstration or stop by booth #MS6051 during the event.
This year Optos is a sponsor of the “Battle at the Sands: Imaging Track” competition where industry leaders, such as Dr. Mo Rafieetary, will present complex patient studies where imaging played a key role in diagnosis and treatment (and compete for bragging rights). After the winner is crowned, please join us at the workshop Wednesday, September 18th from 5-7pm in room 505 at the Sands Convention Center. Seats are limited.
Optos will also be participating in the OCT workshop, and demonstrating the functionality of our Monaco device — the only clinically-validated, 200-degree UWF retinal imaging device with integrated OCT. Monaco produces a 200-degree, single-capture optomap image in less than ½ second and also provides cross-sectional, 40-degree OCT views of retinal structures. Join us Thursday the 19th from 12:30-2:30pm and Friday the 20th from 12:15-2:15 in room 505 to explore the benefits of Optos UWF and OCT.
Age-related macular degeneration (AMD) is a leading cause of blindness in the United States, affecting most commonly, people over the age of 60 with increasing chances as you age, if you are overweight or if you have a family history of AMD.
As we approach our golden years, we are at a higher risk for particular eye diseases including age-related macular degeneration, cataracts, diabetic retinopathy, glaucoma, as well as eye conditions such as dry eye and low vision. More than 40 million Americans are currently 65 years or older, this number is expected to grow to more than 88 million by 2050 and not coincidentally, the number of Americans with age-related eye diseases is expected to double. Early detection and treatment are key to saving sight.
For some, AMD advances so slowly that vision loss does not occur for a long time. In others, the disease progresses faster and may lead to a loss of vision in one or both eyes. The loss of central vision in AMD can interfere with simple everyday activities, such as the ability to see faces, drive, read, write, or do close work, such as cooking or fixing things around the house.